Results 91 to 100 of about 722,373 (248)

Catheter Ablation or Surgical Therapy in Severe Atrial Functional Mitral Regurgitation Caused by Long‐Standing Persistent Atrial Fibrillation—Propensity Score Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background There is no consensus on the treatment strategy for patients with severe atrial functional mitral regurgitation combined with heart failure (HF), with a lack of comparative studies in patients with long‐standing persistent atrial fibrillation ...
Qing Ye, Yuqi Li, Wenbo Zhang, Yichen Zhao, Cheng Zhao, Zonglin Li, Fei Li, Yan Yao, Jiangang Wang   +8 more
doaj   +1 more source

Non-valvular atrial fibrillation and stroke : implications for management [PDF]

, 1995
Nonvalvular Atrial Fibrillation is more prevalent with increasing age. It is associated with a six-fold excess risk of stroke; and a cumulative lifetime stroke risk of 35%. 15% of ischaemic strokes are directly attributable to it.
Tilney, Myra Kay
core  

Catheter ablation of persistent and long-standing persistent atrial fibrillation. Strategies and results [PDF]

, 2013
Catheter ablation for paroxysmal atrial fibrillation is a meanwhile established therapy option, which is most frequently performed using radiofrequency ablation. Mid-term success rate of 70 % are achievable with a single ablation procedure.
Steven, Daniel, Lüker, Jakob, Willems, Stephan, Servatius, Helge, Hoffmann, Boris, Sultan, Arian, Schäffer, Benjamin   +6 more
core   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation

Journal of Education, Health and Sport, 2017
Objectives: In this study, the serum level of matrix metalloproteinase-9 was studied as an independent predictor of recurrence after catheter ablation of a persistent form of atrial fibrillation. Methods: The study included 46 patients with a persistent
A. V. Goryachiy, A. I. Gozhenko, E. M. Levchenko, V. V. Goriachyi, M. A. Kuznetsova, M. I. Arapu   +5 more
doaj   +3 more sources

Comparison of efficacy and safety between cryoballoon ablation and electrical cardioversion for treatment of first-episode persistent atrial fibrillation

Neike lilun yu shijian
ObjectiveTo compare the efficacy and safety of cryoballoon ablation versus electrical cardioversion in patients with first-episode, untreated persistent atrial fibrillation.
Yue WEI, Yangyang BAO, Qingzhi LUO, Yun XIE, Changjian LIN, Ning ZHANG, Qi JIN, Tianyou LING, Liqun WU   +8 more
doaj   +1 more source

A case of non-invasive topical diagnostics with successful ablation during persistent atrial fibrillation

Российский кардиологический журнал, 2019
Treatment of persistent and long-persistent forms of atrial fibrillation remains a pressing issue. Using a personalized approach can help to more successfully eliminate arrhythmias and reduce the return probability.
E. A. Archakov, R. E. Batalov, S. Yu. Usenkov, M. S. Khlynin, A. V. Smorgon, I. V. Kisteneva, S. V. Popov   +6 more
doaj   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

New Procedure for Treatment of Atrial Fibrillation in Patients with Valvular Heart Disease [PDF]

Acta Medica Iranica, 2010
Patients with valvular heart disease suffer from atrial fibrillation for more than 12 months after valve surgery and have a low probability of remaining in sinus rhythm. We performed an intra-operative procedure similar to surgical maze ІІІ procedure for
Naser Safaie, Nasrollah Maghamipour, Ahmad Reza Jodati, Ata Mahmoodpoor, Leila Dashtaki, Masoud Hakimzadeh   +5 more
doaj   +1 more source